0000000000190081

AUTHOR

Jacqueline Gelfi

showing 4 related works from this author

Myxoma virus Leukemia-associated protein is responsible for major histocompatibility complex class I and Fas-CD95 down-regulation and defines scrapin…

2002

ABSTRACTDown-modulation of major histocompatibility class I (MHC-I) molecules is a viral strategy for survival in the host.Myxoma virus, a member of thePoxviridaefamily responsible for rabbit myxomatosis, can down-modulate the expression of MHC-I molecules, but the viral factor(s) has not been described. We cloned and characterized a gene coding for an endoplasmic reticulum (ER)-resident protein containing an atypical zinc finger and two transmembrane domains, which we called myxoma virus leukemia-associated protein (MV-LAP). MV-LAP down-regulated surface MHC-I and Fas-CD95 molecules upon transfection; the mechanism probably involves an exacerbation of endocytosis and was lost when the ER r…

ImmunologyMolecular Sequence DataDown-RegulationMyxoma virusReceptors Cell SurfaceMajor histocompatibility complexEndoplasmic ReticulumMicrobiologyVirusCell Line03 medical and health sciencesViral ProteinsMyxomatosis InfectiousVirologymedicineAnimalsFACTEUR VIRALPoxviridaeAGRONOMIEAmino Acid Sequencefas ReceptorComputingMilieux_MISCELLANEOUS030304 developmental biology[SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology0303 health sciencesBIOTECHNOLOGIEMyxomatosisbiologyBase SequenceVirulence030302 biochemistry & molecular biologyHistocompatibility Antigens Class IMyxoma virusMembrane ProteinsER retentionSequence Analysis DNAbiology.organism_classificationmedicine.diseaseVirology3. Good healthCTL*Lytic cycleInsect Science[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virologybiology.proteinPathogenesis and ImmunityReceptors VirusRabbitsT-Lymphocytes Cytotoxic
researchProduct

Protection of rabbits against rabbit viral haemorrhagic disease with a vaccinia-RHDV recombinant virus

1996

In order to protect domestic and wild rabbits against RVHD, we constructed a recombinant vaccinia-RHDV virus, using the Copenhagen strain of the vaccinia virus. This recombinant virus expressed the RHDV capsid protein (VP60). Analysis of the expressed product showed that the recombinant protein, which is 60 kDa in size, was antigenic as revealed by its reactions in immunoprecipitation and indirect immunofluorescence with the antibodies raised against RHDV. The recombinant virus induced high level of RHDV specific antibodies in rabbits following immunization. Inoculations by both the intradermal and oral routes allow protection of animals against a challenge with virulent RHDV.

Injections IntradermalHemorrhagic Disease Virus Rabbitviruses[SDV]Life Sciences [q-bio]Administration OralVaccinia virusGenome ViralBiologyAntibodies ViralRecombinant virusVirusCell Linelaw.invention03 medical and health scienceschemistry.chemical_compoundlawAnimalsPoxviridaeOrthopoxvirusComputingMilieux_MISCELLANEOUSCaliciviridae Infections030304 developmental biologyViral Structural ProteinsVaccines Synthetic0303 health sciencesGeneral VeterinaryGeneral Immunology and Microbiology030306 microbiologyPublic Health Environmental and Occupational HealthViral Vaccinesbiology.organism_classificationVirologyCaliciviridae3. Good health[SDV] Life Sciences [q-bio]Infectious DiseaseschemistryCapsidRecombinant DNAMolecular MedicineVACCINATIONRabbitsVaccinia
researchProduct

Determinants essential for the transmissible gastroenteritis virus-receptor interaction reside within a domain of aminopeptidase-N that is distinct f…

1994

The swine-specific coronavirus transmissible gastroenteritis virus (TGEV) uses pig aminopeptidase-N (pAPN) as a cellular receptor. We showed that the human aminopeptidase-N (hAPN) cannot substitute for pAPN in this respect, although the two enzymes have 80% amino acid sequence identity. In order to map the TGEV binding site on pAPN, we constructed a series of APN cDNA chimeras between pAPN and hAPN and analyzed them for their capacity to confer infectivity. The region between residues 717 and 813 was found to be essential for infectivity. This region also contains the epitopes for three TGEV-blocking monoclonal antibodies directed against pAPN. These data support the view that the catalytic…

SwineImmunologyMolecular Sequence DataBiologyCD13 Antigensmedicine.disease_causeVirus ReplicationMicrobiologyAminopeptidaseAminopeptidasesEpitopeVirusCatalysis03 medical and health sciencesSpecies SpecificityVirologymedicineVIRUS DE LA GASTROENTERITE TRANSMISSIBLEAnimalsHumansAmino Acid SequenceBinding siteCloning MolecularPeptide sequenceComputingMilieux_MISCELLANEOUS030304 developmental biologyCoronavirusInfectivity[SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology0303 health sciencesBinding SitesBase Sequence030302 biochemistry & molecular biologyTransmissible gastroenteritis virusVirology3. Good healthViral replicationMutagenesisInsect ScienceDNA Viral[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyReceptors VirusResearch Article
researchProduct

Protection against myxomatosis and rabbit viral hemorrhagic disease with recombinant myxoma viruses expressing rabbit hemorrhagic disease virus capsi…

1996

Two myxoma virus-rabbit hemorrhagic disease virus (RHDV) recombinant viruses were constructed with the SG33 strain of myxoma virus to protect rabbits against myxomatosis and rabbit viral hemorrhagic disease. These recombinant viruses expressed the RHDV capsid protein (VP60). The recombinant protein, which is 60 kDa in size, was antigenic, as revealed by its reaction in immunoprecipitation with antibodies raised against RHDV. Both recombinant viruses induced high levels of RHDV- and myxoma virus-specific antibodies in rabbits after immunization. Inoculations by the intradermal route protected animals against virulent RHDV and myxoma virus challenges.

RNA virusesHemorrhagic Disease Virus Rabbitanimal diseasesvirusesLeporipoxviruslaw.invention0403 veterinary sciencelawVIRUS RECOMBINEComputingMilieux_MISCELLANEOUSCaliciviridae Infections[SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology0303 health sciencesVaccines SyntheticMyxomatosisLagovirus04 agricultural and veterinary sciences3. Good healthLagovirusCapsid[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyRecombinant DNAcardiovascular systemRabbitsReassortant VirusesLeporipoxvirusResearch Article040301 veterinary sciencesImmunologyDNA RecombinantMyxoma virusBiologyMicrobiologyVirus03 medical and health sciencesMyxomatosis InfectiousImmunity reactionsVirologyReassortant VirusesmedicineAnimalsRabbit diseasesRecombinant vaccinescardiovascular diseasesImmune response030304 developmental biologyViral Structural ProteinsViral infectionsMyxoma virusbiology.organism_classificationmedicine.diseaseVirologyMédecine vétérinaire et santé animalInsect ScienceExperimental infectionsDNA ViralDNA virusesJournal of virology
researchProduct